Clinical Trial Update: Ph II Bevacizumab + Etoposide for Pts w Recurrent MG [Phase 2]

View source ↗

Summary

Phase II study evaluating bevacizumab plus etoposide in patients with recurrent malignant glioma (glioblastoma and gliosarcoma) completed; results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Gliosarcoma

Drugs mentioned

• Avastin (bevacizumab)
• Etoposide (Etoposide)

Snippet

Sponsor: Duke University | Conditions: Glioblastoma, Gliosarcoma | Phase 2 | Status: COMPLETED | Results posted: 2013-07-26